What Are the Clinical Implications?
death, bleeding, AF, stroke, drug‐based
STROKE, BLEEDING, ATRIAL FIBRILLATION (AF), CARDIAC ARREST

Despite clinically effective ablation, women with AF averaged persistently lower follow‐up quality of life scores than men with AF.Women with atrial fibrillation (AF) generally report worse quality of life (QOL) compared with men, with more AF symptoms and more associated functional impairment.CABANA was a National Institutes of Health–funded, randomized controlled trial designed to test the hypothesis that ablation‐based therapy of AF is more effective than drug‐based therapy for the reduction of a composite end point consisting of death, disabling stroke, serious bleeding, or cardiac arrest.